Nomura Asset Management Co. Ltd. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 504,483 shares of the healthcare conglomerate’s stock after selling 12,501 shares during the quarter. Nomura Asset Management Co. Ltd. owned 0.06% of UnitedHealth Group worth $166,535,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the company. PARUS FINANCE UK Ltd raised its holdings in shares of UnitedHealth Group by 15.9% in the 4th quarter. PARUS FINANCE UK Ltd now owns 28,110 shares of the healthcare conglomerate’s stock worth $9,279,000 after purchasing an additional 3,850 shares during the period. Verity & Verity LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $1,065,000. Texas Yale Capital Corp. raised its holdings in shares of UnitedHealth Group by 78.6% during the 4th quarter. Texas Yale Capital Corp. now owns 6,200 shares of the healthcare conglomerate’s stock valued at $2,047,000 after buying an additional 2,728 shares during the period. Impact Partnership Wealth LLC raised its holdings in shares of UnitedHealth Group by 15.9% during the 4th quarter. Impact Partnership Wealth LLC now owns 2,525 shares of the healthcare conglomerate’s stock valued at $834,000 after buying an additional 347 shares during the period. Finally, Koss Olinger Consulting LLC raised its holdings in shares of UnitedHealth Group by 5.3% during the 4th quarter. Koss Olinger Consulting LLC now owns 1,032 shares of the healthcare conglomerate’s stock valued at $341,000 after buying an additional 52 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 800 shares of the business’s stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares in the company, valued at $6,320,775. The trade was a 4.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.28% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on UNH
UnitedHealth Group Price Performance
Shares of UNH opened at $379.70 on Friday. The firm has a market cap of $344.82 billion, a price-to-earnings ratio of 28.68, a PEG ratio of 1.64 and a beta of 0.64. The stock has a 50 day moving average of $336.85 and a 200-day moving average of $321.55. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $404.15.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping the consensus estimate of $6.76 by $0.47. The company had revenue of $111.65 billion during the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The business’s revenue was up 2.0% on a year-over-year basis. During the same quarter last year, the firm earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 18.29 EPS for the current year.
Key UnitedHealth Group News
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: UnitedHealthcare said it will eliminate prior authorization requirements for nearly two-thirds of pediatric services by year-end. That could reduce administrative friction, improve patient/provider relations, and support customer satisfaction. Reuters article
- Positive Sentiment: Bernstein raised its price target on UNH to $492 from $444 and kept an Outperform rating, citing an EPS recovery outlook. Higher price targets from analysts can help reinforce investor confidence. Yahoo Finance article
- Neutral Sentiment: Berkshire Hathaway fully exited its UNH stake, which is drawing attention to valuation and regulatory risks. While not necessarily a fundamental change, the sale may weigh on sentiment around the stock. Yahoo Finance article
- Negative Sentiment: Massachusetts filed a lawsuit against a UnitedHealth insurance unit, alleging more than $100 million in Medicaid fraud tied to inflated illness severity claims. The lawsuit adds legal and reputational risk for UNH. Investing.com article
About UnitedHealth Group
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
See Also
- Five stocks we like better than UnitedHealth Group
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
